RAP use from their announcement:
Potential customers ofResApp’s products include healthcare providers in telehealth, emergency department, urgent care and primary care settings as well as humanitarian organisations in the developing world.
RAP Study:
The Breathe Easy adult prospective study has completed recruitment, with 956 patients recruited.The study targeted diagnosis of lower respiratory tract disease, pneumonia, asthmaexacerbations and chronic obstructive pulmonary disease (COPD) exacerbations
If you want to know about asthma exacerbations, read:
https://www.healthline.com/health/asthma/acute-asthma-exacerbation
Now make up your own mind about what the RSH vs RAP (competition or not)
RAP use from their announcement: Potential customers ofResApp’s...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.80M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95363 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 199999 | 1 |
View Market Depth
| Last trade - 16.12pm 01/07/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable